Incidence and prognostic significance of karyotypic subgroups in older patients with acute myeloid leukemia: the Swedish population-based experience

被引:47
作者
Lazarevic, V. [1 ,2 ]
Horstedt, A-S [3 ]
Johansson, B. [4 ,5 ]
Antunovic, P. [6 ]
Billstrom, R. [7 ]
Derolf, A. [8 ,9 ]
Hulegardh, E. [10 ]
Lehmann, S. [8 ,9 ]
Mollgard, L. [10 ]
Nilsson, C. [8 ,9 ]
Peterson, S. [3 ]
Stockelberg, D. [10 ]
Uggla, B. [11 ]
Wennstrom, L. [10 ]
Wahlin, A. [12 ]
Hoglund, M. [13 ]
Juliusson, G. [1 ,2 ]
机构
[1] Skane Univ Hosp, Dept Hematol & Coagulat, Lund, Sweden
[2] Lund Univ, Stem Cell Ctr, Dept Hematol Transplantat, Lund, Sweden
[3] Skane Univ Hosp, Reg Canc Ctr South Sweden, Lund, Sweden
[4] Univ & Reg Labs Reg Skane, Dept Clin Genet, Lund, Sweden
[5] Lund Univ, Dept Lab Med, Div Clin Genet, Lund, Sweden
[6] Linkoping Univ Hosp, Dept Hematol, S-58185 Linkoping, Sweden
[7] Cent Hosp Skovde, Dept Med, S-54185 Skovde, Sweden
[8] Karolinska Univ Hosp, Hematol Ctr, Huddinge, Sweden
[9] Karolinska Univ Hosp, Hematol Ctr, Stockholm, Sweden
[10] Sahlgrens Univ Hosp, Dept Med, Gothenburg, Sweden
[11] Orebro Univ Hosp, Dept Med, Orebro, Sweden
[12] Umea Univ, Dept Radiat Sci, Umea, Sweden
[13] Acad Hosp, Dept Hematol, Uppsala, Sweden
关键词
STEM-CELL TRANSPLANTATION; MONOSOMAL KARYOTYPE; ELDERLY-PATIENTS; COMPLETE REMISSION; REAL-WORLD; AML; CYTOGENETICS; SURVIVAL; INDUCTION; YOUNGER;
D O I
10.1038/bcj.2014.10
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Swedish population-based acute myeloid leukemia registry contains data from 3251 patients (excluding acute promyelocytic leukemia) diagnosed between 1997 and 2006. Informative cytogenetic data from 1893 patients were retrospectively added, including 1054 patients aged between 60 and 79 years. Clonal abnormalities were found in 57% of the informative karyotypes. Karyotypic patterns differed by age: t(8; 21), inv(16) and t(11q23) were more common in younger patients, whereas loss of 5q, 7q and 17p, monosomal karyotype (MK) and complex karyotypes were more common in older patients. Loss of 5q, 7q and 17p often occurred together within MK. Patients with >= 5 chromosome abnormalities had worse overall survival than those with fewer abnormalities or normal karyotype in all age groups. Loss of 5q, 7q and/or 17p had, in contrast to MK, a further negative impact on survival. Multivariable Cox regression analyses on risk factors in patients <80 years with cytogenetic abnormalities and intensive treatment revealed that age and performance status had the most significant impact on survival (both P<0.001), followed by sex (P = 0.0135) and a karyotype including - 7/del(7q) (P = 0.048).
引用
收藏
页码:e188 / e188
页数:7
相关论文
共 38 条
[1]  
Bacher U, 2005, HAEMATOLOGICA, V90, P1502
[2]   Monosomal karyotype in acute myeloid leukemia:: A better indicator of poor prognosis than a complex karyotype [J].
Breems, Dimitri A. ;
Van Putten, Wim L. J. ;
De Greef, Georgine E. ;
Van Zelderen-Bhola, Shama L. ;
Gerssen-Schoorl, Klasien B. J. ;
Mellink, Clemens H. M. ;
Nieuwint, Aggie ;
Jotterand, Martine ;
Hagemeijer, Anne ;
Beverloo, H. Berna ;
Lowenberg, Bob .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (29) :4791-4797
[3]   Optimization of Chemotherapy for Younger Patients With Acute Myeloid Leukemia: Results of the Medical Research Council AML15 Trial [J].
Burnett, Alan K. ;
Russell, Nigel H. ;
Hills, Robert K. ;
Hunter, Ann E. ;
Kjeldsen, Lars ;
Yin, John ;
Gibson, Brenda E. S. ;
Wheatley, Keith ;
Milligan, Donald ;
Kjeldsen, Lars .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (27) :3360-+
[4]   Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia:: results from Cancer and Leukemia Group B (CALGB 8461) [J].
Byrd, JC ;
Mrózek, K ;
Dodge, RK ;
Carroll, AJ ;
Edwards, CG ;
Arthur, DC ;
Pettenati, MJ ;
Patil, SR ;
Rao, KW ;
Watson, MS ;
Koduru, PRK ;
Moore, JO ;
Stone, RM ;
Mayer, RJ ;
Feldman, EJ ;
Davey, FR ;
Schiffer, CA ;
Larson, RA ;
Bloomfield, CD .
BLOOD, 2002, 100 (13) :4325-4336
[5]   Cytogenetic profile of de novo acute myeloid leukemia: a study based on 1432 patients in a single institution of China [J].
Cheng, Y. ;
Wang, Y. ;
Wang, H. ;
Chen, Z. ;
Lou, J. ;
Xu, H. ;
Wang, H. ;
Qian, W. ;
Meng, H. ;
Lin, M. ;
Jin, J. .
LEUKEMIA, 2009, 23 (10) :1801-1806
[6]   The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach [J].
Cornelissen, Jan J. ;
Gratwohl, Alois ;
Schlenk, Richard F. ;
Sierra, Jorge ;
Bornhaeuser, Martin ;
Juliusson, Gunnar ;
Racil, Zdenek ;
Rowe, Jacob M. ;
Russell, Nigel ;
Mohty, Mohamad ;
Lowenberg, Bob ;
Socie, Gerard ;
Niederwieser, Dietger ;
Ossenkoppele, Gert J. .
NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (10) :579-590
[7]   Comparative Analysis of the Value of Allogeneic Hematopoietic Stem-Cell Transplantation in Acute Myeloid Leukemia With Monosomal Karyotype Versus Other Cytogenetic Risk Categories [J].
Cornelissen, Jan J. ;
Breems, Dimitri ;
van Putten, Wim L. J. ;
Gratwohl, Alois A. ;
Passweg, Jakob R. ;
Pabst, Thomas ;
Maertens, Johan ;
Beverloo, H. Berna ;
Kooy, Marinus van Marwijk ;
Wijermans, Pierre W. ;
Biemond, Bart J. ;
Vellenga, Edo ;
Verdonck, Leo F. ;
Ossenkoppele, Gert J. ;
Lowenberg, Bob .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (17) :2140-2146
[8]   Integrative prognostic risk score in acute myeloid leukemia with normal karyotype [J].
Damm, Frederik ;
Heuser, Michael ;
Morgan, Michael ;
Wagner, Katharina ;
Goerlich, Kerstin ;
Grosshennig, Anika ;
Hamwi, Iyas ;
Thol, Felicitas ;
Surdziel, Ewa ;
Fiedler, Walter ;
Luebbert, Michael ;
Kanz, Lothar ;
Reuter, Christoph ;
Heil, Gerhard ;
Delwel, Ruud ;
Lowenberg, Bob ;
Valk, Peter J. M. ;
Krauter, Juergen ;
Ganser, Arnold .
BLOOD, 2011, 117 (17) :4561-4568
[9]   Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet [J].
Doehner, Hartmut ;
Estey, Elihu H. ;
Amadori, Sergio ;
Appelbaum, Frederick R. ;
Buechner, Thomas ;
Burnett, Alan K. ;
Dombret, Herve ;
Fenaux, Pierre ;
Grimwade, David ;
Larson, Richard A. ;
Lo-Coco, Francesco ;
Naoe, Tomoki ;
Niederwieser, Dietger ;
Ossenkoppele, Gert J. ;
Sanz, Miguel A. ;
Sierra, Jorge ;
Tallman, Martin S. ;
Loewenberg, Bob ;
Bloomfield, Clara D. .
BLOOD, 2010, 115 (03) :453-474
[10]   Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia:: results from Cancer and Leukemia Group B 8461 [J].
Farag, Sherif S. ;
Archer, Kellie J. ;
Mrozek, Krzysztof ;
Ruppert, Amy S. ;
Carroll, Andrew J. ;
Vardiman, James W. ;
Pettenati, Mark J. ;
Baer, Maria R. ;
Qumsiyeh, Mazin B. ;
Koduru, Prasad R. ;
Ning, Yi ;
Mayer, Robert J. ;
Stone, Richard M. ;
Larson, Richard A. ;
Bloomfield, Clara D. .
BLOOD, 2006, 108 (01) :63-73